Advanced Medical Research Company Profile
Background
Overview
Advanced Medical Research (AMR) is an independent, multi-therapeutic outpatient clinical research center located in Maumee, Ohio. Founded in 2005 by Dr. Nizar Daboul, a board-certified internist with over 25 years of clinical research experience, AMR is dedicated to advancing medical science through high-quality clinical trials.
Mission and Vision
AMR's mission is to provide comprehensive clinical research services that contribute to the development of effective medical treatments. The center aims to bridge the gap between scientific discovery and real-world applications, ensuring that innovative therapies are accessible to patients in a timely manner.
Primary Area of Focus
AMR specializes in conducting clinical trials across various therapeutic areas, including cardiovascular diseases, metabolic disorders, and chronic conditions. The center is committed to advancing medical knowledge and improving patient outcomes through rigorous research methodologies.
Industry Significance
As a dedicated clinical research center, AMR plays a crucial role in the medical research ecosystem by facilitating the development of new treatments and therapies. Its commitment to quality and patient safety ensures that clinical trials meet or exceed industry standards, thereby contributing to the advancement of medical therapeutics.
Key Strategic Focus
Core Objectives
- Conduct High-Quality Clinical Trials: AMR is dedicated to executing clinical studies that adhere to the highest standards of scientific integrity and regulatory compliance.
- Enhance Patient Access to Innovative Therapies: By participating in clinical trials, AMR provides patients with early access to cutting-edge treatments that may not yet be available through conventional medical channels.
- Foster Collaborative Research Partnerships: AMR collaborates with pharmaceutical companies, biotechnology firms, and contract research organizations (CROs) to facilitate the development and approval of new medical therapies.
Specific Areas of Specialization
AMR focuses on a range of therapeutic areas, including:
- Cardiovascular Diseases: Research on conditions such as high blood pressure, heart disease, and heart failure.
- Metabolic Disorders: Studies related to type II diabetes, obesity, and high cholesterol.
- Chronic Conditions: Investigations into chronic kidney disease, stroke, and asthma.
Key Technologies Utilized
AMR employs advanced clinical research methodologies and technologies to ensure the accuracy and reliability of its studies. This includes the use of electronic data capture systems, patient monitoring tools, and data analytics platforms to streamline trial processes and enhance data integrity.
Primary Markets and Conditions Targeted
AMR primarily targets the U.S. healthcare market, focusing on conditions prevalent among the adult population, such as cardiovascular diseases, metabolic disorders, and chronic illnesses. The center's strategic location in Maumee, Ohio, allows it to serve a diverse patient population, facilitating robust patient recruitment and retention for clinical trials.
Financials and Funding
Funding History
Specific details regarding AMR's funding history, including total funds raised and recent funding rounds, are not publicly disclosed. As an independent clinical research center, AMR primarily operates through partnerships with pharmaceutical companies, biotechnology firms, and CROs, which provide funding for individual clinical trials.
Notable Investors
Information about individual investors or venture capital involvement in AMR is not publicly available. The center's financial backing is primarily derived from contractual agreements with research sponsors and partners.
Intended Utilization of Capital
Funds received from research sponsors are allocated towards:
- Clinical Trial Operations: Covering costs associated with patient recruitment, data collection, and analysis.
- Facility Maintenance and Upgrades: Ensuring that research facilities are equipped with state-of-the-art technology and comply with regulatory standards.
- Staff Training and Development: Investing in continuous education and training programs for research staff to maintain high standards of clinical practice.
Pipeline Development
Key Pipeline Candidates
AMR's pipeline development is centered around facilitating clinical trials for various pharmaceutical and biotechnology companies. While specific details about pipeline candidates are not publicly disclosed, the center has been involved in studies related to:
- Cardiovascular Treatments: Investigating new medications and interventions for heart disease and related conditions.
- Metabolic Disorder Therapies: Evaluating treatments for type II diabetes, obesity, and associated metabolic issues.
- Chronic Disease Management: Assessing therapies for chronic kidney disease, stroke rehabilitation, and asthma management.
Stages of Clinical Trials
AMR conducts clinical trials across various phases, including:
- Phase II to Phase IV Trials: Focusing on the efficacy and safety of treatments in larger patient populations.
Target Conditions
The center's clinical trials target a range of conditions, such as:
- Hypertension and Heart Disease: Exploring new pharmacological interventions.
- Type II Diabetes and Obesity: Investigating weight management and glucose control therapies.
- Chronic Kidney Disease and Stroke: Developing treatments to slow disease progression and improve recovery outcomes.
Relevant Timelines for Anticipated Milestones
Specific timelines for clinical trial milestones are determined by the sponsors and regulatory bodies. AMR collaborates closely with these entities to ensure that trials progress efficiently and meet predefined objectives.
Technological Platform and Innovation
Proprietary Technologies
AMR utilizes proprietary clinical research methodologies and data management systems to enhance the efficiency and accuracy of its trials. While specific proprietary technologies are not detailed publicly, the center emphasizes the use of advanced tools to support research activities.
Significant Scientific Methods
- Electronic Data Capture (EDC): Implementing EDC systems to streamline data collection and reduce errors.
- Patient Monitoring Tools: Utilizing advanced monitoring equipment to ensure patient safety and collect accurate data.
- Data Analytics Platforms: Employing analytics tools to interpret complex data sets and derive meaningful insights.
AI-Driven Capabilities
While specific AI-driven capabilities are not publicly disclosed, AMR is committed to integrating innovative technologies to enhance research outcomes.
Leadership Team
Key Executive Profiles
- Dr. Nizar Daboul, M.D. – Primary Investigator
Dr. Daboul is a board-certified internist with over 25 years of experience in clinical research. He founded AMR in 2005 and has been instrumental in its growth and success. Dr. Daboul focuses on cardiovascular and metabolic health and is dedicated to advancing medical research through high-quality clinical trials.
- Nidaa Khamousia, M.D. – Sub-Investigator
Dr. Khamousia is recognized as a top internal medicine doctor, known for her dedication to patient care and her contributions to clinical research. She plays a key role in supporting AMR's research initiatives.
- Kristy Nutter, APRN-CNP – Sub-Investigator
Kristy is a nurse practitioner with a deep commitment to patient care and clinical research. She contributes significantly to AMR's research projects, ensuring high standards of patient safety and data integrity.
- Rachael Irelan, LPN – Site Manager, Clinical Research Coordinator, Research Nurse
Rachael has over 21 years of experience in healthcare, with 13 years as a nurse. She joined AMR in 2018 and was promoted to Site Manager in 2021. Rachael oversees daily operations and coordinates clinical research activities.
- Julie Ngo, MSW – Regulatory Specialist
Julie holds a bachelor's and master's degree in social work and has over 19 years of research experience. She ensures that AMR's clinical trials comply with all regulatory requirements and ethical standards.
- Melissa Keaton – Clinical Research Coordinator
Melissa has over 30 years of experience in healthcare, including roles in phlebotomy and as a medical assistant. She joined AMR in 2024 and coordinates various aspects of clinical research projects.
- Lisa Craig, CMA – Clinical Research Coordinator
Lisa began her medical career in 2016 and became a registered medical assistant in 2018. She joined AMR in 2024 and plays a key role in supporting clinical research activities.
- Lori G. Hyde-Goldberg – Clinical Research Coordinator
Lori has a diverse background in healthcare and law, bringing a multifaceted skill set to AMR.
